
Synthetic GHRH analog peptide for in-vitro laboratory characterisation.
Tesamorelin 5 mg is not yet released for sale. Batch release, HPLC certification and third-party testing are in progress — check back shortly.
Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH), stabilised at its N-terminus. It is one of the more widely referenced GHRH analogs in in-vitro laboratory literature owing to its defined structure and stability profile.
Every vial supplied by NXT GEN PEPTIDES is manufactured to strict laboratory standards, HPLC-characterised and independently third-party tested for identity and purity.
Tesamorelin is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of Tesamorelin supplied by NXT GEN PEPTIDES is HPLC-characterised and independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Store lyophilised at -20 °C. After reconstitution, store at 2–8 °C and use within 28 days.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Triple agonist research peptide (GLP-1/GIP/glucagon).

Larger-format triple agonist research peptide (GLP-1/GIP/glucagon) — 40 mg vial.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.
This site sells research chemicals for in-vitro laboratory research only. You must be 18+ to enter. A full research-use questionnaire and acknowledgements will be required before you can place an order.
Research use only · Not for human or animal consumption